OBJECTIVES: Normally, sonic hedgehog (Shh) is expressed in the pancreas during fetal development and transiently after tissue injury. Although pancreatic cancers express Shh, it is not known if the protein is secreted into the blood and whether its plasma levels change with pancreatic transformation. The goal of this study was to develop an enzyme-linked immunosorbent assay to detect human Shh in blood and determine its levels in subjects with and without pancreatic cancer. METHODS: A human Shh enzyme-linked immunosorbent assay was developed, and plasma Shh levels were measured in blood samples from healthy subjects and patients with pancreatitis or pancreatic cancer. The biological activity of plasma Shh was tested using NIH-3T3 cells. RESULTS: The mean levels of Shh in human blood were lower in patients with pancreatitis and pancreatic cancer than in healthy subjects. Hematopoietic cells did not express Shh, suggesting that Shh is secreted into the bloodstream. Plasma fractions enriched with Shh did not induce Gli-1 messenger RNA, suggesting that the protein was not biologically active. CONCLUSIONS: Shh is secreted from tissues and organs into the circulation, but its activity is blocked by plasma proteins. Reduced plasma levels were found in pancreatic cancer patients, but alone were not sufficient to predict pancreatic cancer.
OBJECTIVES:Normally, sonic hedgehog (Shh) is expressed in the pancreas during fetal development and transiently after tissue injury. Although pancreatic cancers express Shh, it is not known if the protein is secreted into the blood and whether its plasma levels change with pancreatic transformation. The goal of this study was to develop an enzyme-linked immunosorbent assay to detect humanShh in blood and determine its levels in subjects with and without pancreatic cancer. METHODS: A humanShh enzyme-linked immunosorbent assay was developed, and plasma Shh levels were measured in blood samples from healthy subjects and patients with pancreatitis or pancreatic cancer. The biological activity of plasma Shh was tested using NIH-3T3 cells. RESULTS: The mean levels of Shh in human blood were lower in patients with pancreatitis and pancreatic cancer than in healthy subjects. Hematopoietic cells did not express Shh, suggesting that Shh is secreted into the bloodstream. Plasma fractions enriched with Shh did not induce Gli-1 messenger RNA, suggesting that the protein was not biologically active. CONCLUSIONS:Shh is secreted from tissues and organs into the circulation, but its activity is blocked by plasma proteins. Reduced plasma levels were found in pancreatic cancerpatients, but alone were not sufficient to predict pancreatic cancer.
Authors: Yana Zavros; Meghna Waghray; Arthur Tessier; Longchuan Bai; Andrea Todisco; Deborah L Gumucio; Linda C Samuelson; Andrzej Dlugosz; Juanita L Merchant Journal: J Biol Chem Date: 2007-09-14 Impact factor: 5.157
Authors: W M Steinberg; R Gelfand; K K Anderson; J Glenn; S H Kurtzman; W F Sindelar; P P Toskes Journal: Gastroenterology Date: 1986-02 Impact factor: 22.682
Authors: Sarah P Thayer; Marina Pasca di Magliano; Patrick W Heiser; Corinne M Nielsen; Drucilla J Roberts; Gregory Y Lauwers; Yan Ping Qi; Stephan Gysin; Carlos Fernández-del Castillo; Vijay Yajnik; Bozena Antoniu; Martin McMahon; Andrew L Warshaw; Matthias Hebrok Journal: Nature Date: 2003-09-14 Impact factor: 49.962
Authors: A S Noman; M Uddin; A A Chowdhury; M J Nayeem; Z Raihan; M I Rashid; A K Azad; M L Rahman; D Barua; A Sultana; A Shirin; J Ferdous; R R Parag; S M Rahman; M R Mahmud; C S Jerin; N Jahan; A Siddiqua; T Ara; E B Sabur; S S Alam; S Baidya; S Akther; M Z Rahman; T Banu; A K Murugan; S Sabri; S M S Islam; B Karakas; A Aboussekhra; H Yeger; W A Farhat; S S Islam Journal: Sci Rep Date: 2017-05-11 Impact factor: 4.379
Authors: Raffaele Teperino; Fritz Aberger; Harald Esterbauer; Natalia Riobo; John Andrew Pospisilik Journal: Semin Cell Dev Biol Date: 2014-05-23 Impact factor: 7.727
Authors: Daniel V T Catenacci; Melissa R Junttila; Theodore Karrison; Nathan Bahary; Margit N Horiba; Sreenivasa R Nattam; Robert Marsh; James Wallace; Mark Kozloff; Lakshmi Rajdev; Deirdre Cohen; James Wade; Bethany Sleckman; Heinz-Josef Lenz; Patrick Stiff; Pankaj Kumar; Peng Xu; Les Henderson; Naoko Takebe; Ravi Salgia; Xi Wang; Walter M Stadler; Frederic J de Sauvage; Hedy L Kindler Journal: J Clin Oncol Date: 2015-11-02 Impact factor: 44.544